Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Achieve appoints Dr. Mark Rubenstein as CMO

Achieve Life Sciences (NASDAQ: ACHV) has announced the promotion of Mark Rubenstein, MD, from interim chief medical officer (CMO) to CMO. Dr. Rubinstein brings more than two decades of experience in clinical medicine...

January 12, 2026

Executive Moves

Biodexa appoints Fiona Sharp as CFO and company secretary

Biodexa Pharmaceuticals (NASDAQ: BDRX) has announced the promotion of Fiona Sharp to chief financial officer (CFO) and company secretary—in addition to her election to the board of directors—effective immediately. The...

January 5, 2026

Executive Moves

PureTech appoints Robert Lyne as CEO

PureTech Health (NASDAQ: PRTC; LSE: PRTC) has announced the appointment of Robert Lyne as chief executive officer (CEO), and member of the board of directors, effective immediately. Mr. Lyne has served as interim CEO...

December 18, 2025

Executive Moves

Brooke Story joins PolyPid as chair of the BOD

PolyPid (NASDAQ: PYPD) has announced the appointment of medtech leader Brooke Story as chair of the board of directors (BOD), effective December 11, 2025. Ms. Story brings more than 25 years of leadership experience in...

December 16, 2025

Executive Moves

ENvue appoints David Johnson as chairman

ENvue Medical (NASDAQ: FEED) announced the appointment of David Johnson as chairman of the board. Mr. Johnson is a seasoned healthcare executive and board leader with more than 30 years of experience across the medical...

December 15, 2025

Executive Moves

Cadrenal appoints Dr. Lee Golden to BOD

Cadrenal Therapeutics (NASDAQ: CVKD) has announced the appointment of Lee Scott Golden, MD, to its board of directors (BOD) as an independent director, effective immediately. Dr. Golden currently serves as EVP and CMO...

December 1, 2025

Executive Moves

Dr. Mark Jaroszeski joins Aspire’s scientific team

Aspire Biopharma (NASDAQ: ASBP) has announced the addition of tenured professor, department of medical engineering, University of South Florida, Mark J. Jaroszeski, PhD, to its scientific team. Dr. Jaroszeski is a...

November 26, 2025

Executive Moves

Joe Dawson joins Rockwell’s BOD

Rockwell Medical (NASDAQ: RMTI) has announced the appointment of Joe Dawson to its board of directors (BOD), and the resignation of Andrea Heslin Smiley from its BOD. Mr. Dawson brings more than 25 years of experience...

November 18, 2025

Executive Moves

Cibus elects Craig Wichner to BOD

Cibus (NASDAQ: CBUS) has announced the election of Craig Wichner to its Board of Directors (BOD) and the board’s strategy committee. “Craig brings an exceptional combination of financial acumen, strategic discipline...

November 11, 2025

Executive Moves

Mary-Elizabeth Gifford joins Clearmind as Chief of Global Impact

Clearmind Medicine (NASDAQ: CMND; FSE: CWY0) has announced the appointment of Mary-Elizabeth Gifford as chief of global impact. Prior to joining Clearmind, Gifford served as chief of global impact at Psyence BioMed, a...

October 27, 2025

Executive Moves

Three key appointments strengthen Amphista’s clinical development capabilities

Closely held Amphista Therapeutics has announced the appointments of Dr. Lisa Butler as SVP of clinical operations, Dr. Alexandra Sevko as VP of translational science, and Nicola Lindsay as head of project and portfolio...

October 23, 2025

Executive Moves

Dr. Bali Pulendran joins Candel’s research advisory board

Candel Therapeutics (NASDAQ: CADL) has announced the appointment of internationally recognized expert in systems immunology and vaccinology, Bali Pulendran, PhD, to Candel’s research advisory board. Dr. Pulendran is the...

October 16, 2025

Executive Moves

James Rawls, PharmD, joins LB as SVP of regulatory affairs

LB Pharmaceuticals (NASDAQ: LBRX) has announced the appointment of James Rawls, PharmD, as senior vice president (SVP) of regulatory affairs. With more than 25 years of regulatory leadership experience across global...

October 14, 2025

Executive Moves

Cantargia appoints Dr. Wolfram Dempke as CMO

Cantargia (Nasdaq Stockholm: CANTA) has announced the appointment of Wolfram Dempke, MD, PhD, MBA as chief medical officer (CMO), effective immediately. Dr. Morten Lind Jensen, who has served as CMO since March 2025...

October 2, 2025

Executive Moves

Dr. Tiffany Inglis joins Sera as CMO

Sera Prognostics (NASDAQ: SERA) has announced the appointment of Tiffany Inglis, MD, FACOG, as chief medical officer (CMO). Dr. Inglis brings extensive clinical leadership expertise to Sera. As CMO, she will lead...

October 1, 2025

Executive Moves

Dr. Usman Azam appointed president and CEO of Cue

Cue Biopharma (NASDAQ: CUE) has announced that Usman Azam, MD has been appointed president and CEO of Cue Biopharma, effective today. Daniel Passeri will transition from his current role as CEO to one of strategic...

September 30, 2025

Executive Moves

Onco appoints Dr. Michael Lock to scientific and clinical advisory board

Onco-Innovations (CBOE CA: ONCO; Frankfurt: W1H, WKN: A3EKSZ; OTCQB: ONNVF) has announced the appointment of staff radiation oncologist, Dr. Michael Lock, to its scientific and clinical advisory board. Dr. Lock is a...

September 23, 2025

Executive Moves

Lucid appoints policy leader Danielle Scelfo as SVP, Market Access & Gov’t Affairs

Lucid Diagnostics (NASDAQ: LUCD) announced the appointment of Danielle Scelfo as SVP, Market Access & Government Affairs, reporting to the CEO. With more than 25 years of strategic and operational experience across...

September 16, 2025

Executive Moves

ALX appoints Dr. Barbara Klencke as interim CMO

ALX Oncology Holdings (NASDAQ: ALXO) has announced the appointment of board member Barbara Klencke, MD, as interim chief medical officer, (CMO). According to ALX, Dr. Alan Sandler is departing from the role of CMO and...

September 12, 2025

Executive Moves

MedX appoints Dr. Paul Matts as strategic advisor

MedX Health (TSXV: MDX) has announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist, and educator, as strategic advisor. Dr. Matts is an academic and industry leader, as...

September 9, 2025

Executive Moves

Tatjana Mitchell joins Evolus as CFO

Evolus (NASDAQ: EOLS) has announced the appointment of Tatjana Mitchell as chief financial officer (CFO), effective today. Ms. Mitchell brings more than 20 years of strategic and operational finance leadership across...

September 8, 2025

Executive Moves

Dr. Thomas J. Errico elected electroCore’s chairman of the board; Peter Cuneo retires

electroCore (NASDAQ: ECOR) has announced the election of Thomas J. Errico, MD, as chairman of the board and the departure of Peter Cuneo from its board of directors (BOD). According to electroCore, Mr. Cuneo will...

September 5, 2025

Subscribe